Literature DB >> 2436735

Screening for maternal serum alpha-fetoprotein: what about the low side?

A Lippman, J A Evans.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2436735      PMCID: PMC1492091     

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  27 in total

1.  Screening for Down's syndrome using serum alpha fetoprotein.

Authors:  H S Cuckle; N J Wald
Journal:  Br Med J (Clin Res Ed)       Date:  1985-08-03

2.  Wrongful birth, wrongful life: the doctor between a rock and a hard place.

Authors:  R R Lenke; J M Nemes
Journal:  Obstet Gynecol       Date:  1985-11       Impact factor: 7.661

3.  Maternal serum alpha-fetoprotein screening of fetal trisomies.

Authors:  D W Hershey; B F Crandall; P S Schroth
Journal:  Am J Obstet Gynecol       Date:  1985-09-15       Impact factor: 8.661

4.  Screening for Down's syndrome in the North East Thames region.

Authors:  V Murday; J Slack
Journal:  Br Med J (Clin Res Ed)       Date:  1985-11-09

5.  Maternal serum alpha-fetoprotein screening for neural tube defects. Report of a combined study in Germany and short overview on screening in populations with low birth prevalence of neural tube defects.

Authors:  W Fuhrmann; H K Weitzel
Journal:  Hum Genet       Date:  1985       Impact factor: 4.132

6.  Randomised controlled trial of genetic amniocentesis in 4606 low-risk women.

Authors:  A Tabor; J Philip; M Madsen; J Bang; E B Obel; B Nørgaard-Pedersen
Journal:  Lancet       Date:  1986-06-07       Impact factor: 79.321

7.  Critical issues in prenatal maternal serum alpha-fetoprotein screening for genetic anomalies.

Authors:  J N Macri
Journal:  Am J Obstet Gynecol       Date:  1986-08       Impact factor: 8.661

8.  Maternal age and amniocentesis: should this be lowered to 30 years?

Authors:  B F Crandall; T B Lebherz; K Tabsh
Journal:  Prenat Diagn       Date:  1986 Jul-Aug       Impact factor: 3.050

9.  Utilization of prenatal cytogenetic diagnosis in women of advanced maternal age in Australia, 1979-1982.

Authors:  J A Bell; J Pearn; G Cohen; J Ford; J Halliday; N Martin; M Mulcahy; S Purvis-Smith; G Sutherland
Journal:  Prenat Diagn       Date:  1985 Jan-Feb       Impact factor: 3.050

10.  Maternal serum alpha-fetoprotein and fetal autosomal trisomies.

Authors:  T A Doran; K Cadesky; P Y Wong; C Mastrogiacomo; T Capello
Journal:  Am J Obstet Gynecol       Date:  1986-02       Impact factor: 8.661

View more
  7 in total

1.  Non-invasive prenatal testing.

Authors:  B C McGillivray
Journal:  Can Fam Physician       Date:  1988-04       Impact factor: 3.275

2.  Screening in pregnancy.

Authors:  A Biringer
Journal:  Can Fam Physician       Date:  1988-09       Impact factor: 3.275

Review 3.  First trimester ultrasound tests alone or in combination with first trimester serum tests for Down's syndrome screening.

Authors:  S Kate Alldred; Yemisi Takwoingi; Boliang Guo; Mary Pennant; Jonathan J Deeks; James P Neilson; Zarko Alfirevic
Journal:  Cochrane Database Syst Rev       Date:  2017-03-15

Review 4.  First and second trimester serum tests with and without first trimester ultrasound tests for Down's syndrome screening.

Authors:  S Kate Alldred; Yemisi Takwoingi; Boliang Guo; Mary Pennant; Jonathan J Deeks; James P Neilson; Zarko Alfirevic
Journal:  Cochrane Database Syst Rev       Date:  2017-03-15

Review 5.  Second trimester serum tests for Down's Syndrome screening.

Authors:  S Kate Alldred; Jonathan J Deeks; Boliang Guo; James P Neilson; Zarko Alfirevic
Journal:  Cochrane Database Syst Rev       Date:  2012-06-13

Review 6.  First trimester serum tests for Down's syndrome screening.

Authors:  S Kate Alldred; Yemisi Takwoingi; Boliang Guo; Mary Pennant; Jonathan J Deeks; James P Neilson; Zarko Alfirevic
Journal:  Cochrane Database Syst Rev       Date:  2015-11-30

Review 7.  Urine tests for Down's syndrome screening.

Authors:  S Kate Alldred; Boliang Guo; Yemisi Takwoingi; Mary Pennant; Susanna Wisniewski; Jonathan J Deeks; James P Neilson; Zarko Alfirevic
Journal:  Cochrane Database Syst Rev       Date:  2015-12-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.